摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis-4-(benzyloxy)cyclohexanol | 127074-28-6

中文名称
——
中文别名
——
英文名称
cis-4-(benzyloxy)cyclohexanol
英文别名
cis-4-Benzyloxy-cyclohexanol
cis-4-(benzyloxy)cyclohexanol化学式
CAS
127074-28-6
化学式
C13H18O2
mdl
——
分子量
206.285
InChiKey
GDGBMTDJFHTXID-BETUJISGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    321.9±35.0 °C(Predicted)
  • 密度:
    1.07±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.51
  • 重原子数:
    15.0
  • 可旋转键数:
    3.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    29.46
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    cis-4-(benzyloxy)cyclohexanolcaesium carbonate三乙胺 作用下, 以 二氯甲烷N,N-二甲基乙酰胺 为溶剂, 反应 19.0h, 生成
    参考文献:
    名称:
    Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis
    摘要:
    Calcium dependent protein kinase 1 (CDPK1) is an essential Ser/Thr kinase that controls invasion and egress by the protozoan parasite Toxoplasma gondii. The Gly gatekeeper of CDPK1 makes it exquisitely sensitive to inhibition by small molecule 1H-pyrazolo[3,4-d]pyrimidine-4-amine (PP) compounds that are bulky ATP mimetics. Here we rationally designed, synthesized, and tested a series of novel PP analogs that were evaluated for inhibition of CDPK1 enzyme activity in vitro and parasite growth in cell culture. Optimal substitution on the PP scaffold included 2-pyridyl ethers directed into the hydrophobic pocket and small carbocyclic rings accessing the ribose-binding pocket. Further optimization of the series led to identification of the lead compound 3a that displayed excellent potency, selectivity, safety profile, and efficacy in vivo. The results of these studies provide a foundation for further work to optimize CDPK1 inhibitors for the treatment of acute and chronic toxoplasmosis.
    DOI:
    10.1021/acs.jmedchem.0c00419
  • 作为产物:
    描述:
    ((cyclohex-3-enyloxy)methyl)benzene 在 lithium aluminium tetrahydride 、 间氯过氧苯甲酸 作用下, 以 乙醚二氯甲烷 为溶剂, 反应 4.25h, 生成 cis-4-(benzyloxy)cyclohexanol
    参考文献:
    名称:
    Regiochemical control of the ring-opening of 1,2-epoxides by means of chelating processes. Synthesis and reactions of the cis- and trans-oxides derived from 4-(benzyloxy)cyclohexene
    摘要:
    DOI:
    10.1021/jo00301a011
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO NTRK<br/>[FR] COMPOSÉS ET COMPOSITIONS UTILES POUR TRAITER DES TROUBLES ASSOCIÉS AU GÈNE NTRK
    申请人:BLUEPRINT MEDICINES CORP
    公开号:WO2017035354A1
    公开(公告)日:2017-03-02
    This invention relates to inhibitors of NTRK that are active against wild-type NTRK and its resistant mutants.
    这项发明涉及对NTRK的抑制剂,对野生型NTRK及其耐药突变体具有活性。
  • Generalization, Alteration, and Enhancement of the Stereoselectivity in the Cieplak-Mode Reductions of 4-Alkoxy(or Silyloxy)cyclohexanones
    作者:Yoshimitsu Nagao、Michimasa Goto、Masahito Ochiai
    DOI:10.1246/cl.1990.1507
    日期:1990.9
    Reductions of 4-alkoxy(or silyloxy)cyclohexanones with LiAlH4, AlH(i-Bu)2, and Li(s-Bu)3BH afforded the corresponding cis alcohols in 73–80% selectivities. Similar reduction of 4-benzyloxy- and 4-t-butyldiphenylsilyloxy-cyclohexanones with AlH(i-Bu)2 in the presence of EtAlCl2 gave trans alcohol (93% selectivity) from the former and cis alcohol (94% selectivity) from the latter, respectively.
    用LiAlH4、AlH(i-Bu)2和Li(s-Bu)3BH还原4-烷氧基(或氧基)环己酮可以获得相应的顺式醇,选择性为73-80%。在EtAlCl2存在下,用AlH(i-Bu)2对4-苄氧基和4-t-丁基二苯基氧基环己酮进行类似还原,前者获得反式醇(选择性为93%),后者获得顺式醇(选择性为94%)。
  • Trifluoromethyl-Substituted Indenyl Rhodium and Iridium Complexes Are Highly Selective Catalysts for Directed Hydroboration Reactions
    作者:John A. Brinkman、Tam T. Nguyen、John R. Sowa
    DOI:10.1021/ol005653z
    日期:2000.4.1
    Rhodium and iridium catalysts containing trifluoromethyl-substituted indenyl ligands (Ind'MCod, Ind' = C9H7, (1-CF3)C9H6, (2-CF3)C9H6, (1,3-CF3)2C9H5) have been developed for the directed hydroboration of 4-(benzyloxy)cyclohexene to cis-3-(benzyloxy)cyclohexanol. Compared to unsubstituted complexes, trifluoromethyl substitution yields a 3-10% increase in selectivity which is attributed to the strong
    已开发出含三甲基取代的配体(Ind'MCod,Ind'= C9H7,(1-CF3C9H6,(2- ) ,(1,3- )2C9H5)的催化剂4-(苄氧基)环己烯形成顺式-3-(苄氧基)环己醇。与未取代的配合物相比,三甲基取代的选择性提高了3-10%,这归因于三甲基的强大的吸电子作用。配合物的选择性为74-84%,配合物的选择性很高(93-98%)。
  • Einige Derivate und Umwandlungsprodukte des Chinits
    作者:D. A. Prins
    DOI:10.1002/hlca.19570400609
    日期:——
    A preparative method is given for the partial benzylation of quinitol to 4-benzyloxy-cyclohexanol. This compound was oxidized to 4-benzyloxy-cyclohexanone, which on alkylation furnished methyl 5-benzyloxy-2-oxo-cyclohexylacetate.
    给出了一种制备方法,用于将奎尼醇部分苄基化为4-苄氧基-环己醇。将该化合物氧化为4-苄氧基-环己酮,其在烷基化时提供乙酸甲基5-苄氧基-2-氧-环己酯。
  • Compounds and compositions useful for treating disorders related to NTRK
    申请人:BLUEPRINT MEDICINES CORPORATION
    公开号:US10017512B2
    公开(公告)日:2018-07-10
    This disclosure relates to inhibitors of NTRK that are active against wild-type NTRK and its resistant mutants, such as compounds of Formula (I):
    本公开涉及对野生型 NTRK 及其抗性突变体有活性的 NTRK 抑制剂,如式 (I) 化合物:
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫